Jie Zhang
Lawyers
Advises corporate and private equity clients on M&A, including pre-IPO financings, buyouts, JVs, PIPEs, de-SPAC, going-private transactions and strategic investments.
Jie is counsel in our Corporate practice, currently practicing as a Registered Foreign Lawyer in Beijing. Jie’s practice focuses on advising corporate clients and private equity funds on M&A matters, including pre-IPO financings, buyouts, joint ventures, PIPEs, de-SPAC transactions, going-private transactions and strategic investments. She also advises clients on securities law and general corporate matters.
Experience highlights
Mergers & Acquisitions
- Provident Acquisition on the $1.02 billion combination with Perfect
- The special committee on the going-private transaction of New Frontier Health
- The special committee on the going-private transaction of 51job
- UP Fintech on its $65 million convertible notes private placement
- The special committee on the going-private transaction of China Biologic Products
- Tencent on the going-private transaction of Sogou
- Yintech on its going-private transaction
- Tencent and Tencent Music Entertainment on the acquisition by a Tencent-led consortium of a 20% equity stake in Universal Music Group from Vivendi
- Tencent on its investment in Tuhu
- Comcast Spectacor on its T1 esports joint venture with SK Telecom
- Unitas Capital’s sale of Jiahao Foods to Huabao International Holdings for approximately $694 million
- iKang Healthcare on its acquisition by Yunfeng Capital and Alibaba
- Tencent and Tencent Music Entertainment on their investments in Spotify, and on the cross-shareholding by Spotify in Tencent Music Entertainment
- China Biologic Products on its acquisition of 80% equity interest in Tianxinfu for approximately $513 million
- China Biologic Products redomiciles from Delaware to the Cayman Islands by its merging with and into its wholly owned subsidiary China Biologic Products
- Tencent on its acquisition of China Music Corporation
- Meituan Corporation on its strategic cooperation with DianPing
- Special committee of Origin Agritech on its sale of commercial seed production and distribution business
- China Biologic Products on its $590 million private placement
- Sequoia on its various investments in pre-IPO companies, including Ke, Julive and Genesis Medtech
- Megvii Technology on its pre-IPO financing
- iQiyi on its $1.53 billion convertible notes financing
- UCAR Technology on its $550 million Series B equity financing
- IDG Capital Partners on its investment in SouFun
Capital Markets
- Sinopec Group Overseas Development $3 billion senior notes offering
- Hong Yang Group $125 million high-yield notes offering
- Logan Property Holdings $200 and $450 million senior notes offerings
- Shandong Yuhuang Chemical $300 million high-yield notes offering
- China Aoyuan Property $250 Million high-yield notes offering
- Toyota Motor Credit Corporation $750 million offering in Taiwan
- Toyota Motor Credit Corporation $1.75 billion offering
Education
J.D., Harvard Law School
- cum laude
Ph.D., Cancer Biology, University of Chicago
B.S., Biological Sciences, Peking University
- with high honors
Professional history
- Counsel - Registered Foreign Lawyer, 2022-present
- Registered Foreign Lawyer, 2014-2021
Qualifications and admissions
- Beijing Ministry of Justice - Registered
- State of New York